Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Basic cancer research in Québec].

Michel L Tremblay1

  • 1Centre de recherche sur le cancer de l'Université McGill, 3655 promenade Sir William Osler, McIntyre Medical Sciences Building, Université McGill, Montréal, Québec, Canada, H3G 1Y6. michel.tremblay@mcgill.ca

Bulletin Du Cancer
|September 19, 2006
PubMed
Summary
This summary is machine-generated.

Quebec

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

PTPN1/PTPN2 inhibition improves NK cancer therapy by enhancing IL-2 and mitigating TGFβ1 responses.

EMBO reports·2026
Same author

Uncovering the individual immunotherapeutic roles of PTPN1 and PTPN2 in T cells during dual inhibition.

iScience·2025
Same author

Leishmania donovani's protein tyrosine phosphatases interact with DUF21 and respond to environmental magnesium.

The FEBS journal·2025
Same author

Translon: a single term for translated regions.

Nature methods·2025
Same author

Impact of culture vessel materials on biomanufacturing of dendritic cell-based immunotherapies in closed systems.

Biomaterials science·2025
Same author

PTPN2 Negatively Regulates Macrophage Immune Responses and Cellular Bioenergetics.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2025
Same journal

[Update: Evolution in the management of metastatic urothelial carcinomas].

Bulletin du cancer·2026
Same journal

[ONCONNECTE À L'EMPLOI, feedback after three years of a program to prepare for returning to work after cancer in Franche-Comté].

Bulletin du cancer·2026
Same journal

[Off-label use of venetoclax in myeloma].

Bulletin du cancer·2026
Same journal

[Cemiplimab - Adjuvant treatment for the cutaneous squamous cell carcinomas with high risk of relapse, operated and treated by radiotherapy].

Bulletin du cancer·2026
Same journal

Real-world outcomes and management of endometrial cancer in France from 2016 to 2021 (MOONBEAM study).

Bulletin du cancer·2026
Same journal

[Cardiotoxicity in children and adolescents with acute leukemia: Recommendations from the Leukemia Committee of the French Society of Childhood Cancer (SFCE)].

Bulletin du cancer·2026
See all related articles

Area of Science:

  • Oncology
  • Biomedical Research

Context:

  • Development of cancer research institutes in Quebec.
  • Improved scientific infrastructure and programs.

Purpose:

  • To assess the performance of oncology research in Quebec.
  • To highlight the province's growing research capabilities.

Summary:

  • Oncology research in Quebec shows high performance based on impact factors and publications.
  • Institutes in Quebec are leaders in biomedical research within the province.

Impact:

  • Quebec's oncology research is internationally competitive.
  • Collaborations and advanced platforms enhance participation in global studies.